James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

St. Jude shows growth in third quarter

Third-quarter data bolster a strong 2013 for the Little Canada-based medical technology company, analysts said.

Updated: October 16, 2013, - 07:58 PM

St. Jude acquires wireless pacemaker company

The Little Canada firm has acquired Nanostim, maker of the world’s first “leadless” pacemaker, in a $123.5 million deal.

Updated: October 14, 2013, - 12:01 AM

Boomers' embrace of devices gives rise to new med-tech age

Rapid growth of medical devices in middle-age patients renews lives, remakes industry and raises worries over long-term use.

Updated: September 18, 2013, - 09:31 AM

Raceway Park in Shakopee calls it quits after 60 years

After nearly 60 years of cars thundering around its paved oval, Raceway Park has held its final races, ever. Plans now call for the track to become home to an asphalt recycling plant to be built by Recovery Technology Solutions.

Updated: September 01, 2013, - 09:51 PM

Study touts benefits of orthotics, prosthetics

A report by an amputee advocacy group said the devices, while expensive, lower costs in the long run.

Updated: August 28, 2013, - 09:29 AM

Medtronic’s profit rises, but stock closes lower

Solid gains in profit and revenue still left Wall Street analysts with nagging concerns.

Updated: August 20, 2013, - 08:54 PM

Medafor of Brooklyn Center is sold to unit of C.R. Bard

After fighting off a hostile bid in 2010, Medafor’s owners will get $200 million, plus incentives that could add another...

Updated: August 19, 2013, - 08:20 PM

Medtronic buys Cardiocom, a remote monitor pioneer in Chanhassen

The deal for the Chanhassen firm will help Medtronic expand into a market that’s expected to grow because of new...

Updated: August 13, 2013, - 06:15 AM

Medtronic device will collect data as it treats brain disorders

The Medtronic device isn’t FDA-approved for commercial use yet, but it could help researchers better understand and treat diseases like...

Updated: August 07, 2013, - 09:04 PM

Boston Scientific profit tops estimates; shares soar

The med-tech giant reported better results than analysts expected and raised its forecast.

Updated: July 25, 2013, - 09:12 PM

Result Per Page


Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters


Golden Gavel by Star Tribune

Time left for great deals

Bid thru Sept. 29